{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:54Z","timestamp":1789609134945,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jceh.2022.12.008","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:42:33Z","timestamp":1671774153000},"page":"698-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Strategies for ABO Incompatible Liver Transplantation"],"prefix":"10.1016","volume":"13","author":[{"given":"Shekhar S.","family":"Jadaun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaleen","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5677-7140","authenticated-orcid":false,"given":"Sanjiv","family":"Saigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2022.12.008_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/cld.673","article-title":"ABO-incompatible liver transplantation: Is It a Viable Option With Modern Innovation?","author":"Goss","year":"2017","journal-title":"Clinical Liver Disease"},{"key":"10.1016\/j.jceh.2022.12.008_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/TP.0b013e3181adcae6","article-title":"Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation","volume":"88","author":"Ikegami","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.12.008_bib3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.transproceed.2004.12.114","article-title":"New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange","volume":"37","author":"Kawagishi","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2022.12.008_bib4","first-page":"231","article-title":"Human ABO-incompatible living donor renal homografts","volume":"28","author":"Alexandre","year":"1985","journal-title":"Neth J Med"},{"key":"10.1016\/j.jceh.2022.12.008_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/ajt.13444","article-title":"ABO-incompatible adult living donor liver transplantation under the desensitization protocol with rituximab","volume":"16","author":"Song","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2019.0023","article-title":"Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation","volume":"26","author":"Oh","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2022.12.008_bib7","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/01.TP.0000082723.02477.87","article-title":"Rituximab with plasmapheresis and splenectomy in abo-incompatible liver transplantation","volume":"76","author":"Monteiro","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.12.008_bib8","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.transproceed.2004.08.094","article-title":"Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report","volume":"36","author":"Nakamura","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2022.12.008_bib9","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/00007890-200206270-00021","article-title":"Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation","volume":"73","author":"Tanabe","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.12.008_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/ajt.12520","article-title":"Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study","volume":"14","author":"Egawa","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib11","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/00007890-199504270-00009","article-title":"The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients","volume":"59","author":"Farges","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.12.008_bib12","unstructured":"The ABO Blood Group - Blood Groups and Red Cell Antigens - NCBI Bookshelf. https:\/\/www.ncbi.nlm.nih.gov\/sites\/books\/NBK2267\/?msclkid=a5865a72cedb11eca29e053e58a41e84. Accessed 8 May 2022."},{"key":"10.1016\/j.jceh.2022.12.008_bib13","first-page":"4401","article-title":"ABH antigens: some basic aspects","volume":"19","author":"Samuelsson","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2022.12.008_bib14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2362.2010.02339.x","article-title":"Current progress in ABO-incompatible liver transplantation","volume":"40","author":"Tanabe","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jceh.2022.12.008_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.hbpd.2020.06.017","article-title":"Challenge to ABO blood type barrier in living donor liver transplantation","volume":"19","author":"Egawa","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jceh.2022.12.008_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/lt.20002","article-title":"Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation","volume":"10","author":"Haga","year":"2004","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/lt.20652","article-title":"Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation","volume":"12","author":"Haga","year":"2006","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.gtc.2017.01.005","article-title":"Antibody-mediated rejection after liver transplant","volume":"46","author":"Lee","year":"2017","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.jceh.2022.12.008_bib19","doi-asserted-by":"crossref","DOI":"10.15761\/CCRR.1000221","article-title":"Current aspects of ABO-incompatible liver transplantation","author":"Kawagishi","year":"2016","journal-title":"Clin Case Rep Rev"},{"key":"10.1016\/j.jceh.2022.12.008_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.TP.0000110295.88926.5C","article-title":"Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation","volume":"77","author":"Egawa","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.12.008_bib21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.TP.0000078622.43689.D4","article-title":"Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab","volume":"76","author":"Tyd\u00e9n","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.12.008_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","article-title":"Rituximab: mechanism of action","volume":"47","author":"Weiner","year":"2010","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jceh.2022.12.008_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/TP.0000000000001849","article-title":"Anti-CD20 blocker rituximab in kidney transplantation","volume":"102","author":"Sood","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.12.008_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2215\/CJN.09430915","article-title":"B\u00a0cells, antibodies, and more","volume":"11","author":"Hoffman","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jceh.2022.12.008_bib25","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-03-3606","article-title":"CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer res 2003;63:2836-2843","volume":"64","author":"von Bergwelt-Baildon","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jceh.2022.12.008_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jhbp.419","article-title":"Optimal dosage regimen for rituximab in ABO-incompatible living donor liver transplantation","volume":"24","author":"Egawa","year":"2017","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jceh.2022.12.008_bib27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/lt.21092","article-title":"B-cell surface marker analysis for\u00a0improvement of rituximab prophylaxis in ABO-incompatible adult\u00a0living donor liver transplantation","volume":"13","author":"Egawa","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib28","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.2174\/1381612826666200506094539","article-title":"ABO-incompatible liver transplantation: state of art and future perspectives","volume":"26","author":"Cheng","year":"2020","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.jceh.2022.12.008_bib29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/bcp.12098","article-title":"Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease","volume":"76","author":"Puisset","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jceh.2022.12.008_bib30","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/j.1600-6143.2006.01497.x","article-title":"Pharmacodynamics of rituximab in kidney allotransplantation","volume":"6","author":"Genberg","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/08830185.2019.1601720","article-title":"ABO-incompatible liver transplantation\u2013A review of the historical background and results","volume":"38","author":"Dahlgren","year":"2019","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.jceh.2022.12.008_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/TP.0000000000001956","article-title":"Feasibility of monotherapy by rituximab without additional desensitization in ABO-incompatible living-donor liver transplantation","volume":"102","author":"Yamamoto","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.12.008_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.hbpd.2018.02.005","article-title":"A\u00a0comparison of desensitization methods: rituximab with\/without plasmapheresis in ABO-incompatible living donor liver transplantation","volume":"17","author":"Lee","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jceh.2022.12.008_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1744-9987.2006.00409.x","article-title":"The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience","volume":"10","author":"Kozaki","year":"2006","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jceh.2022.12.008_bib35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1399-0012.2005.00392.x","article-title":"A\u00a0new concept of accommodation in ABO-incompatible kidney transplantation","volume":"19","author":"Takahashi","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.7599\/hmr.2014.34.4.202","article-title":"ABO incompatability in liver transplantation","volume":"34","author":"Song","year":"2014","journal-title":"Hanyang Med Rev"},{"key":"10.1016\/j.jceh.2022.12.008_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12227","article-title":"Successful ABO incompatible renal transplantation following rituximab and DFPP after failed immunoadsorption","author":"Thalgahagoda","year":"2014","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/tri.12412","article-title":"ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption","volume":"28","author":"de Weerd","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2022.12.008_bib39","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/ndt\/gfr237","article-title":"The efficacy of antigen-specific immunoadsorption and rebound of anti-A\/B antibodies in ABO-incompatible kidney transplantation","volume":"26","author":"Genberg","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.transci.2016.08.007","article-title":"Efficacy of single, extended and goal directed immunoadsorption in ABO incompatible living related donor liver transplantation","volume":"55","author":"Makroo","year":"2016","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jceh.2022.12.008_bib41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.21928","article-title":"Present status of ABO-incompatible living donor liver transplantation in Japan","volume":"47","author":"Egawa","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.12.008_bib42","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jhep.2013.07.035","article-title":"ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor","volume":"59","author":"Kim","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.12.008_bib43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2014.04.039","article-title":"Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era","volume":"61","author":"Song","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.12.008_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00595-010-4437-3","article-title":"Management of ABO-incompatible living-donor liver transplantation: past and present trends","volume":"41","author":"Raut","year":"2011","journal-title":"Surg Today"},{"key":"10.1016\/j.jceh.2022.12.008_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/TP.0b013e318239e8e4","article-title":"Splenectomy does not offer\u00a0immunological benefits in ABO-incompatible liver transplantation\u00a0with a preoperative rituximab","volume":"93","author":"Raut","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.12.008_bib46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00007890-200108150-00010","article-title":"Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients","volume":"72","author":"Luke","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.12.008_bib47","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1034\/j.1600-6143.2003.00121.x","article-title":"Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications","volume":"3","author":"Jordan","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib48","article-title":"Adult living donor liver transplantation across ABO-incompatibility","volume":"94","author":"Lee","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.jceh.2022.12.008_bib49","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.tp.0000173647.43616.78","article-title":"Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression","volume":"80","author":"Shimmura","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.12.008_bib50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1399-3089.2006.00286.x","article-title":"Adult ABO-incompatible liver transplantation, using A and B donors","volume":"13","author":"Skogsberg","year":"2006","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.jceh.2022.12.008_bib51","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4254\/wjh.v7.i10.1355","article-title":"Review on immunosuppression in liver transplantation","volume":"7","author":"Moini","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2022.12.008_bib52","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/lt.20520","article-title":"The renal-sparing efficacy of basiliximab in adult living donor liver transplantation","volume":"11","author":"Lin","year":"2005","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib53","article-title":"Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients","author":"Penninga","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2022.12.008_bib54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/lt.21723","article-title":"ABO-incompatible deceased donor liver transplantation in the United States: a national registry analysis","volume":"15","author":"Stewart","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib55","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1537-2995.1974.tb04576.x","article-title":"Developmental patterns of ABO isoagglutinins in normal children correlated with the effects of age, sex, and maternal isoagglutinins","volume":"14","author":"Fong","year":"1974","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.jceh.2022.12.008_bib56","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1399-3046.2011.01541.x","article-title":"ABO-incompatible pediatric liver transplantation in very small recipients: birmingham's experience","volume":"15","author":"Gelas","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib57","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jamcollsurg.2015.12.041","article-title":"Pediatric liver transplantation across the ABO blood group barrier: is it an obstacle in the modern era?","volume":"222","author":"Rana","year":"2016","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.jceh.2022.12.008_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13263","article-title":"ABO-incompatible deceased donor pediatric liver transplantation: novel titer-based management protocol and outcomes","author":"Mysore","year":"2018","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/children8090760","article-title":"ABO incompatible liver transplantation in children: a 20 year experience from centres in the transplantchild European reference network","author":"Markiewicz-Kijewska","year":"2021","journal-title":"Children"},{"key":"10.1016\/j.jceh.2022.12.008_bib60","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/ajt.14198","article-title":"Adult living donor liver transplantation for acute-on-chronic liver failure in high\u2013model for end-stage liver disease score patients","volume":"17","author":"Moon","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib61","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.transproceed.2013.02.012","article-title":"ABO-incompatible liver transplantation in acute liver failure: a single Portuguese center study","volume":"45","author":"Mendes","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2022.12.008_bib62","first-page":"2833","article-title":"[ABO-incompatible liver transplantation for liver failure]","volume":"87","author":"Yang","year":"2007","journal-title":"Zhonghua Yixue Zazhi"},{"key":"10.1016\/j.jceh.2022.12.008_bib63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/00365521.2021.1976269","article-title":"Excellent outcome following emergency deceased donor ABO-incompatible liver transplantation using rituximab and antigen specific immunoadsorption","volume":"57","author":"Skogsberg Dahlgren","year":"2022","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.12.008_bib64","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1499-3872(14)60268-X","article-title":"A\u00a0modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure","volume":"13","author":"Shen","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jceh.2022.12.008_bib65","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14555","article-title":"Quick preparation of ABO-incompatible living donor liver transplantation for acute liver failure","author":"Lee","year":"2022","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101476","article-title":"Clinical outcomes after ABO-incompatible liver transplantation: a systematic review and meta-analysis","author":"Gan","year":"2021","journal-title":"Transpl Immunol"},{"issue":"suppl 3","key":"10.1016\/j.jceh.2022.12.008_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ajt.14584","article-title":"Antibody-mediated rejection: new approaches in prevention and management","volume":"18","author":"Montgomery","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib68","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1111\/j.1600-6143.2012.04126.x","article-title":"Bortezomib for acute antibody-mediated rejection in liver transplantation","volume":"12","author":"Paterno","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib69","author":"Tajima"},{"key":"10.1016\/j.jceh.2022.12.008_bib70","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/ajt.14228","article-title":"Assessment of Tocilizumab (Anti-Interleukin-6 receptor monoclonal) as a potential treatment for chronic antibody-mediated rejection and transplant glomerulopathy in HLA-sensitized renal allograft recipients","volume":"17","author":"Choi","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib71","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/ajt.12712","article-title":"Renal transplantation using Belatacept without maintenance steroids or Calcineurin inhibitors","volume":"14","author":"Kirk","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1182\/blood-2015-03-634394","article-title":"Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia","volume":"127","author":"Byrd","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2022.12.008_bib73","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1614598","article-title":"Obinutuzumab for the first-line treatment of follicular lymphoma","volume":"377","author":"Marcus","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2022.12.008_bib74","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1111\/ajt.15514","article-title":"Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant","volume":"19","author":"Redfield","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.12.008_bib75","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1097\/TXD.0000000000000683","article-title":"Effect of fc-\u03b3 receptor polymorphism on rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation","volume":"3","author":"Sakai","year":"2017","journal-title":"Transplant Direct"},{"key":"10.1016\/j.jceh.2022.12.008_bib76","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s10620-008-0618-y","article-title":"Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT","volume":"54","author":"Egawa","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2022.12.008_bib77","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/TP.0000000000002154","article-title":"ABO-Incompatible living donor liver transplantation with rituximab and total plasma exchange does not increase hepatocellular carcinoma recurrence","volume":"102","author":"Kim","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.12.008_bib78","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/liv.13614","article-title":"A\u00a0simplified protocol using\u00a0rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation","volume":"38","author":"Kim","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.12.008_bib79","first-page":"91","article-title":"Feasible usage of ABO incompatible grafts in living donor liver transplantation","volume":"5","author":"Ikegami","year":"2016","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.jceh.2022.12.008_bib80","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/TP.0000000000002197","article-title":"Long-term outcomes of ABO-incompatible pediatric living donor liver transplantation","volume":"102","author":"Honda","year":"2018","journal-title":"Transplantation"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322005552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322005552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:09:21Z","timestamp":1760854161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688322005552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0973688322005552"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2022.12.008","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies for ABO Incompatible Liver Transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2022.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}